Complete correction of anemia by erythropoiesis-stimulating agents is associated with insulin resistance in hemodialysis patients

Clinical and Experimental Medicine

Volumn 11, Issue 3, 2011, Pages 181-187

  Biolo, Gianni ^a,c   Guarnieri, Gianfranco ^a   Barazzoni, Rocco ^a   Panzetta, Giovanni ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY HOSPITAL OF TRIESTE   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Anemia; Erythropoietin; Euglycemic hyperinsulinemic clamp; Hemodialysis; Insulin resistance; Stable isotopes

Indexed keywords

GLUCOSE; HEMOGLOBIN; INSULIN; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY FAILURE; MALE; PRIORITY JOURNAL;

ADULT; AGED; ANEMIA; CROSS-SECTIONAL STUDIES; ERYTHROPOIESIS; ERYTHROPOIETIN; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEMATINICS; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 80054879742     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-010-0119-0     Document Type: Article

References (32)

1. Abboud H, Henrich WL (2010) Clinical practice. Stage IV chronic kidney disease. N Engl J Med 362:56-65
2. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584-590 (Pubitemid 28385655)
3. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D, CHOIR Investigators (2006) Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355:2085-2098 (Pubitemid 44749317)
4. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A, CREATE Investigators (2006) Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355:2071-2084 (Pubitemid 44749316)
5. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R, TREAT Investigators (2009) A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361:2019-2032
6. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V, Graziano G, McGee R, Nicolucci A, Tognoni G, Strippoli GF (2010) Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 153:23-33
7. Locatelli F, Aljama P, Canaud B, Covic A, De Francisco A, Macdougall IC, Wiecek A, Vanholder R, On behalf of the Anaemia Working Group of European Renal Best Practice (ERBP) (2010) Target haemoglobin to aim for with erythropoi-esis-stimulating agents: a position statement by ERBP following publication of the Trial to Reduce Cardiovascular Events with Aranesp (R) Therapy (TREAT) Study. Nephrol Dial Transplant. Jun 29. [Epub ahead of print]
8. Manolis AS, Tzeis S, Triantafyllou K, Michaelidis J, Pyrros I, Sakellaris N, Kranidis A, Melita H (2005) Erythropoietin in heart failure and other cardiovascular diseases: hematopoietic and pleiotropic effects. Curr Drug Targets Cardiovasc Haematol Disord 5:355-375 (Pubitemid 41631546)
9. KDOQI (2007) Clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target. Am J Kidney Dis 50:471-530
10. Locatelli F, Nissenson AR, Barrett BJ, Walker RG, Wheeler DC, Eckardt KU, Lameire NH, Eknoyan G (2008) Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 74:1237-1240
11. Portolés JM, de Francisco AL, Górriz JL, Mart́inez-Castelao A, López-Gómez JM, Arias M, de la Cruz JJ, Cases A, Fernández E, Aljama P (2008) Maintenance of target hemoglobin level in stable hemodialysis patients constitutes a theoretical task: a historical prospective study. Kidney Int Suppl 111:S82-S87
12. Gilbertson DT, Peng Y, Bradbury B, Ebben JP, Collins AJ (2009) Hemoglobin level variability: anemia management among variability groups. Am J Nephrol 30:491-498
13. Siew ED, Ikizler TA (2010) Insulin resistance and protein energy metabolism in patients with advanced chronic kidney disease. Semin Dial 23:378-382
14. Ginsberg HN (2000) Insulin resistance and cardiovascular disease. J Clin Invest 106:453-458 (Pubitemid 30666377)
15. Mak RH (1996) Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol 270:F839-F844
16. Allegra V, Mengozzi G, Martimbianco L, Vasile A (1996) Early and late effects of erythropoietin on glucose metabolism in maintenance hemodialysis patients. Am J Nephrol 16:304-308 (Pubitemid 26143579)
17. Spaia S, Pangalos M, Askepidis N, Pazarloglou M, Mavropoulou E, Theodoridis S, Dimitrakopoulos K, Milionis A, Vayonas G (2000) Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients. Nephron 84:320-325 (Pubitemid 30179456)
18. Borel MJ, Beard JL, Farrell PA (1993) Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats. Am J Physiol 264:E380-E390 (Pubitemid 23103950)
19. Minamiyama Y, Takemura S, Kodai S, Shinkawa H, Tsukioka T, Ichikawa H, Naito Y, Yoshikawa T, Okada S (2010) Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab 298:E1140-E1149
20. Hanley AJ, Retnakaran R, Qi Y, Gerstein HC, Perkins B, Raboud J, Harris SB, Zinman B (2009) Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab 94:3824-3832
21. Biolo G, Stulle M, Bianco F, Mengozzi G, Barazzoni R, Vasile A, Panzetta G, Guarnieri G (2008) Insulin action on glucose and protein metabolism during L-carnitine supplementation in maintenance haemodialysis patients. Nephrol Dial Transplant 23:991-997 (Pubitemid 351767549)
22. Chen H, Sullivan G, Quon MJ (2005) Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model. Diabetes 54:1914-1925 (Pubitemid 40911252)
23. Gnaiger E, Kuznetsov AV (2002) Mitochondrial respiration at low levels of oxygen and cytochrome c. Biochem Soc Trans 30:252-258
24. Azevedo JL Jr, Carey JO, Pories WJ, Morris PG, Dohm GL (1995) Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes 44:695-698
25. Chou SW, Chiu LL, Cho YM, Ho HY, Ivy JL, Ho CF, Kuo CH (2004) Effect of prolonged intermittent hypoxia and exercise training on glucose tolerance and muscle GLUT4 protein expression in rats. J Biomed Sci 11:838-846 (Pubitemid 39664238)
26. Sauerwein HP, Schols AM (2002) Glucose metabolism in chronic lung disease. Clin Nutr 21:367-371
27. Bardos JI, Ashcroft M (2005) Negative and positive regulation of HIF-1: a complex network. Biochim Biophys Acta 1755:107-120 (Pubitemid 40982561)
28. Perez-Martin A, Dumortier M, Pierrisnard E, Raynaud E, Mercier J, Brun JF (2001) Multivariate analysis of relationships between insulin sensitivity and blood rheology: is plasma viscosity a marker of insulin resistance? Clin Hemorheol Microcirc 25:91-103 (Pubitemid 34258580)
29. Smith KJ, Bleyer AJ, Little WC, Sane DC (2003) The cardiovascular effects of erythropoietin. Cardiovasc Res 59:538-548 (Pubitemid 38368670)
30. Facchini FS, Carantoni M, Jeppesen J, Reaven GM (1998) Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 47:831-835 (Pubitemid 28313190)
31. Barbieri M, Ragno E, Benvenuti E, Zito GA, Corsi A, Ferrucci L, Paolisso G (2001) New aspects of the insulin resistance syndrome: impact on haematological parameters. Diabetologia 44:1232-1237 (Pubitemid 33010499)
32. McCarty MF (2003) Hyperinsulinemia may boost both hemato-crit and iron absorption by up-regulating activity of hypoxia-inducible factor-1alpha. Med Hypotheses 61:567-573 (Pubitemid 37411901)